Lunai Bioworks Inc.
LNAI
$1.02
-$0.15-12.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -27.19% | -16.14% | 19.57% | 13.21% | 60.32% |
| Depreciation & Amortization | 5.91% | 7.41% | 7.88% | 13.09% | 7.50% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.28% | -23.18% | 15.63% | 13.80% | 39.76% |
| Operating Income | 32.28% | 23.18% | -15.63% | -13.80% | -39.76% |
| Income Before Tax | -101.31% | 30.12% | -206.05% | -199.96% | -122.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.31% | 30.12% | -206.05% | -199.96% | -122.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.31% | 30.12% | -206.05% | -199.96% | -122.82% |
| EBIT | 32.28% | 23.18% | -15.63% | -13.80% | -39.76% |
| EBITDA | 32.45% | 23.32% | -15.67% | -13.80% | -39.95% |
| EPS Basic | -22.24% | 62.50% | -41.82% | -42.91% | -23.25% |
| Normalized Basic EPS | 65.47% | 61.53% | 45.19% | 36.11% | 6.18% |
| EPS Diluted | -22.13% | 62.43% | -41.94% | -43.03% | -23.37% |
| Normalized Diluted EPS | 65.54% | 61.60% | 45.19% | 36.11% | 6.18% |
| Average Basic Shares Outstanding | 68.26% | 111.87% | 136.29% | 105.78% | 73.44% |
| Average Diluted Shares Outstanding | 68.67% | 112.40% | 136.29% | 105.78% | 73.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |